Clinical Trial Update: Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan

View source ↗

Summary

A long-term post-marketing specified drug use survey for evolocumab conducted in Japan has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• Repatha (Evolocumab)

Snippet

Sponsor: Amgen | Conditions: Hypercholesterolemia, Familial Hypercholesterolemia | Status: COMPLETED